Patients that receive heart transplants with DCD hearts have comparable early renal outcomes to patients that receive hearts ...

Roivios, a pioneering clinical-stage medical device company dedicated to revolutionizing kidney health, proudly announces that its research and development arm, 3ive Labs, has secured approval for an ...

Johnson & Johnson JNJ announced that the FDA has issued a complete response letter (“CRL”) to its biologics license ...

Caution is urged with early albumin use in septic shock and kidney impairment, especially with hyperoncotic vs isooncotic albumin.

Dizal announces positive pooled data of sunvozertinib in EGFR TKI-resistant NSCLC: Shanghai, China Friday, December 13, 2024, 18:00 Hrs [IST] Dizal, a biopharmaceutical company co ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Study demonstrates how metabolic imaging differentiates high and low oxidative phosphorylation (OXPHOS) subtypes of ...

Among Taiwan’s non-small cell lung cancer cases, approximately 55 percent involve an EGFR mutation, with deletion of exon 19 and exon 21 the most common mutations, treatable with first to ...

Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.

In a new study published in Lupus Science & Medicine, researchers found a connection between renal (kidney) response and long ...

Greenfire Resources (NYSE:GFR – Get Free Report) is one of 286 publicly-traded companies in the “Crude petroleum & natural gas” industry, but how does it contrast to its rivals? We will compare ...